TNF in the inflammatory response

Chemical Immunology

Volumn 74, Issue , 1999, Pages 141-161

  Mänuel, Daniela N ^a   Echtenacher, Bernd ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; TUMOR NECROSIS FACTOR;

ANTIBACTERIAL ACTIVITY; BACTERIAL IMMUNITY; CHRONIC INFLAMMATION; INFLAMMATION; INFLAMMATORY DISEASE; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; AUTOIMMUNE DISEASES; BLOOD COAGULATION; CELL MOVEMENT; CHRONIC DISEASE; COMPLEMENT SYSTEM PROTEINS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MAST CELLS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, SCID; NEOPLASMS; PAPIO; PERITONITIS; RECEPTORS, TUMOR NECROSIS FACTOR; SHOCK, SEPTIC; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032734462     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Coley WB: The treatment of malignant tumor by repeated inoculations of erysipelas, with a report of 10 original cases. Am J Med Sci 1893;105:487.
2. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zähringer U, Seydel U, Di Padova F: Bacterial endotoxin: Molecular relationships of structure to activity and function. FASEB J 1994;8:217-225.
3. O'Malley WE, Achinstein B, Shear MJ: Journal of the National Cancer Institute, vol 29, 1962:
4. Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance (classical article). Nutr Rev 1988;46:389-391.
5. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B: An endotoxin-induced serum factor that causes necrosis of tumor. Proc Natl Acad Sci USA 1975;72:3666.
6. Aggarwal BB, Kohr WJ, Hass PE, Moffat B, Spencer SA, Henzel WJ, Bringman TS, Nedwin GE, Goeddel DV, Harkin RN: TNF: Production, purifaction, characterization. J Biol Chem 1985;260:2345-2354.
7. Beutler B, Greenwald D, Hulmes JD, Chang M, Pan YC, Mathison J, Ulevitch R, Cerami A: Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 1985;316:552-554.
8. Beutler B, Cerami A: The biology of cachectin/TNF-α primary mediator of the host response. Annu Rev Immunol 1989;7:625-655.
9. Beutler B, Cerami A: Cachectin and TNF as two sides of the same biological coin. Nature 1986;320:584-588.
10. Beyaert R, Fiers W: Tumor necosis factor and lymphotoxin; in Mire-Sluis AR, Thorpe R (eds): Cytokines. London, Academic Press, 1998, pp 335-360.
11. Lejeune F, Lienard D, Eggermont A, Schraffordt Koops H, Rosenkaimer F, Gerain J, Klaase J, Kroon B, Vanderveken J, Schmitz P: Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs: Rationale and results. J Infus Chemother 1995;5:73-81.
12. Hafner M, Orosz P, Krüger A, Männel DN: TNF promotes metastasis by impairing natural killer cell activity. Int J Cancer 1996;66:388-392.
13. Zeni F, Freeman B, Natanson C: Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment. Crit Care Med 1997;25:1095-1100.
14. Spies T, Blanck G, Bresnahan M, Sands J, Strominger JL: A new cluster of genes within the human major histocompatibility complex. Science 1989;243:214-217.
15. Jongeneel CV: The TNF and lymphotoxin promotors; in Beutler B (ed): Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. New York, Raven Press, 1992, pp 539-559.
16. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, et al: A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997;385:729-733.
17. Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Becherer JD: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 1997;385:733-736.
18. Perez C, Albert I, DeFay K, Zachariades N, Gooding L, Kriegler M: A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 1990;63:251-258.
19. Jones EY, Stuart DI, Walker NP: Structure of tumour necrosis factor. Nature 1989;338:225-228.
20. Eck MJ, Sprang SR: The structure of tumor necrosis factor-alpha at 2.6 A resolution: Implications for receptor binding. J Biol Chem 1989;264:17595-17605.
21. Fiers W: Tumor necrosis factor: Characterization at the molecular, cellular and in vivo level. FEBS Lett 1991;285:199-212.
22. Banner DW, D'Arcy A, Janes W, Gentz R, Schoenfeld HJ, Broger C, Loetscher H, Lesslauer W: Crystal structure of the soluble human 55 kD TNF receptor-human TNF beta complex: Implications for TNF receptor activation. Cell 1993;73:431-445.
23. Beutler B (ed): Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. New York, Raven Press, 1992.